Status:
COMPLETED
Tobacco Cessation in Public Housing
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Community Partnership and Collaboration Core Pilot Grant
Conditions:
Smoking Cessation
Smoking Reduction
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The inequity in cessation resources is at forefront in the recently enacted nationwide smoking ban in public housing facilities. The critical component lacking from the federal decree was a practical ...
Detailed Description
Lower socioeconomic populations continue to remain at high risk for tobacco use and suffer disproportionately from tobacco-related disease. Evidence is lacking of ways to optimally deliver behavioral ...
Eligibility Criteria
Inclusion
- ≥18 years of age to 99 years old
- Self-reported smoker with either daily or weekly cigarette use, as well as expressed desire to reduce or quit smoking
- Proof of residence at Douglass or Brooklyn Homes through verbal acknowledgement by the Service Coordinators at each of the public housing sites.
- Working cell phone with ability to text for the duration of the study
- Active health insurance (for pharmacotherapy billing)
Exclusion
- Pregnant - women will verbally acknowledge that they are not pregnant
- Breastfeeding - women who are verbally acknowledge they are breastfeeding will be excluded from the study.
- Ongoing participation in a tobacco cessation program or related tobacco intervention study
- Unable to verbally state that they are willing to reduce or quit smoking upon recruitment and screening
- Adults lacking capacity to consent
- Non-English speakers
- Self-reported usage of only non-combustible tobacco products, such as smokeless tobacco or Electronic Nicotine Delivery Devices (ENDS).
- Anticipated relocation outside of Douglass or Brooklyn Homes prior to the final study visit
Key Trial Info
Start Date :
April 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 18 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04889638
Start Date
April 3 2024
End Date
October 18 2024
Last Update
October 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Creative Alternative
Baltimore, Maryland, United States, 21224